Are Clinical Laboratories in California Accurately Reporting Vancomycin-Resistant Enterococci?
|
|
- Everett Fox
- 6 years ago
- Views:
Transcription
1 JOURNAL OF CLINICAL ROBIOLOGY, Oct. 1997, p Vol. 35, No /97/$ Copyright 1997, American Society for Microbiology Are Clinical Laboratories in California Accurately Reporting Vancomycin-Resistant Enterococci? JON ROSENBERG, 1 * FRED C. TENOVER, 2 JANE WONG, 3 WILLIAM JARVIS, 2 AND DUC J. VUGIA 1 Disease Investigation and Surveillance Branch 1 and Microbial Diseases Laboratory, 3 Division of Communicable Disease Control, California Department of Health Services, Berkeley, California 94704, and Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia Received 3 March 1997/Returned for modification 21 May 1997/Accepted 14 July 1997 In order to determine whether hospital-based clinical laboratories conducting active surveillance for vancomycin-resistant enterococci in three San Francisco Bay area counties (San Francisco, Alameda, and Contra Costa counties) were accurately reporting vancomycin resistance, five vancomycin-resistant enterococcal strains and one vancomycin-susceptible -lactamase-producing enterococcus were sent to 31 of 32 (97%) laboratories conducting surveillance. Each strain was tested by the laboratory s routine antimicrobial susceptibility testing method. An Enterococcus faecium strain with high-level resistance to vancomycin (, 512 g/ml) was correctly reported as resistant by 100% of laboratories; an E. faecium strain with moderate-level resistance (, 64 g/ml) was correctly reported as resistant by 91% of laboratories; two Enterococcus faecalis strains with low-level resistance (s, 32 g/ml) were correctly reported as resistant by 97 and 56% of laboratories, respectively. An Enterococcus gallinarum strain with intrinsic low-level resistance (, 8 g/ml) was correctly reported as intermediate by 50% of laboratories. A -lactamase-producing E. faecalis isolate was correctly identified as susceptible to vancomycin by 100% of laboratories and as resistant to penicillin and ampicillin by 68 and 44% of laboratories, respectively; all 23 (74%) laboratories that tested for -lactamase recognized that it was a -lactamase producer. This survey indicated that for clinically significant enterococcal isolates, laboratories in the San Francisco Bay area have problems in detecting low- to moderate-level but not high-level vancomycin resistance. Increasing accuracy of detection and prompt reporting of these isolates and investigation of cases are the next steps in the battle for control of the spread of vancomycin resistance. Over the past 10 years enterococci have become one of the most important nosocomial pathogens. Intrinsic enterococcal resistance to numerous antimicrobial agents, including -lactams and aminoglycosides, has contributed to their selection as nosocomial pathogens following the introduction of the cephalosporins (19). Subsequently, enterococci have acquired additional resistance through the production of -lactamases (21), altered penicillin-binding proteins (36), and aminoglycoside-modifying enzymes (15). Genetically mediated (33, 37) resistance to the glycopeptide vancomycin is considered one of the most critical examples of enterococcal resistance since (i) additional resistance genes often are present in the same strain, leaving no effective therapeutic agents available to treat infected patients, and (ii) the gene mediating high-level resistance is transferable, raising the potential that vancomycin resistance will spread to other more pathogenic organisms (10). Vancomycin-resistant enterococci were first recovered from clinical isolates in Europe in 1986 (16) and in the United States * Corresponding author. Mailing address: Disease Investigation and Surveillance Branch, Division of Communicable Disease Control, California Department of Health Services, 2151 Berkeley Way, Berkeley, CA Phone: (510) Fax: (510) jrosenbe@hwl.cahwnet.gov. Member of the California Emerging Infections Program, which includes Arthur L. Reingold, School of Public Health, University of California, Berkeley, Calif.; S. Benson Werner, Sharon Abbott, and J. Michael Janda, Division of Communicable Disease Control, California Department of Health Services; and Gretchen Rothrock, Nandeeni Mukerjee, Lisa Gelling, Susan Shallow, Pamela Daily, and Jenny Flood, California Public Health Foundation, Berkeley, Calif. in 1988 (13). Published outbreaks and National Nosocomial Infections Surveillance System data indicate that vancomycin resistance first emerged in the northeastern United States, causing numerous outbreaks (2, 3, 7, 9, 14, 27, 34) and establishing endemicity in a number of locations (18) at a time when little resistance was evident in the western United States. Surveillance is essential to understanding and controlling antimicrobial resistance (8, 11, 17, 20, 25, 32). Surveillance for antimicrobial agent-resistant pathogens should be laboratory based (5, 6, 26) and should include standardized methods for susceptibility testing with quality controls (1, 4). As a component in the California Emerging Infections Program, a collaborative program of the California Department of Health Services, the University of California, Berkeley, School of Public Health, the Centers for Disease Control and Prevention (CDC), and local health departments, active laboratory-based surveillance for vancomycin resistance among enterococcal clinical isolates was initiated in January 1995 at 35 general acute-care hospitals that use 32 microbiology laboratories to perform antimicrobial susceptibility tests in three San Francisco Bay area counties (San Francisco, Alameda, and Contra Costa counties). In January 1995, a survey indicated that all but one of these laboratories had been routinely testing for vancomycin susceptibility of most clinical isolates, including isolates from urine, for at least 1 year; beginning in 1995 all laboratories did so. During 1994, 6 (19%) laboratories reported detecting one or more (range, one to six) vancomycinresistant enterococci. The sensitivity and specificity of the surveillance system for monitoring resistance are dependent upon the abilities of these laboratories to detect vancomycin resistance. Different methods of susceptibility testing have demonstrated variable success 2526
2 VOL. 35, 1997 REPORTING OF VANCOMYCIN-RESISTANT ENTEROCOCCI 2527 Antibiotic Strain 1 (E. faecium VanA) a Strain 2 (E. faecium VanB-like) TABLE 1. Enterococcal strains used in study Strain 3 (E. faecalis VanB-like) Strain 4 (E. faecalis VanB) Strain 5 (E. gallinarum VanC) Strain 6 (E. faecalis) Vancomycin Penicillin b 15 Ampicillin b 19 BL c a Disk diffusion (24). b The clinical significance of the penicillin and ampicillin susceptibility divergence of this strain is unclear. c BL, -lactamase test;, negative reaction;, positive reaction. in detecting vancomycin resistance (28, 30, 31, 35, 37, 39). To determine the abilities of the various antimicrobial susceptibility testing methods used at surveillance study laboratories to detect vancomycin, penicillin, and/or ampicillin resistance, we conducted a proficiency study. MATERIALS AND METHODS Enterococcal strains. Six strains of enterococci (three Enterococcus faecalis, two Enterococcus faecium, and one Enterococcus gallinarum strains), including five strains representing the four most common vancomycin resistance phenotypes (strains 1 to 5; Table 1) and a vancomycin-susceptible -lactamase-producing strain (strain 6; Table 1), were obtained from the CDC strain collection, inoculated onto Trypticase soy agar slants (Becton Dickinson Microbiology Systems [BDMS], Cockeysville, Md.), and sent to the 31 participating laboratories. Susceptibility testing. Each laboratory supervisor was instructed to test the six organisms for resistance to ampicillin, penicillin, and vancomycin by using the antimicrobial susceptibility testing method routinely used at the laboratory and to indicate the and interpretation (susceptible, intermediate, or resistant) or zone size and interpretation on the form provided. After completion of the tests, the forms were sent to the California Department of Health Services and CDC for data entry and analysis. The reported results obtained with the MicroScan Touchscan and AutoSCAN systems were combined. Information on the susceptibility panels (MicroScan) and cards (Vitek) used was obtained after the completion of testing. Reference methods. All reference tests were performed at CDC. Broth microdilution was performed with cation-adjusted Mueller-Hinton broth (BDMS) according to the guidelines of the National Committee for Clinical Laboratory Standards (NCCLS) (23), and disk diffusion was performed with Mueller-Hinton agar and disks from BDMS according to NCCLS guidelines (24). Categorical errors were not calculated for the data because of the small sample sizes. Results were considered to be in agreement if they differed by a single dilution above or below the reference value for the s (38). -Lactamase tests were performed by using the colorimetric cephalosporin nitrocefin (Cefinase; BDMS). RESULTS Thirty-one (97%) of 32 laboratories, representing 34 (97%) of 35 hospitals conducting surveillance for vancomycin-resistant enterococci, participated in the study. One laboratory reported two sets of results obtained by two antimicrobial susceptibility testing methods, and these were counted independently. The methods used for antimicrobial susceptibility testing at participating laboratories varied, with 19 (59%) of 32 laboratories using a MicroScan system (Table 2). Overall, 11 (35%) laboratories used a screen plate consisting of brain heart infusion (BHI) agar containing 6 g of vancomycin per ml as a supplemental method of testing for vancomycin susceptibility (28, 30, 34). Those using MicroScan systems as their primary method were less likely to use a screening plate (3 of 19) than those using the Vitek system (3 of 5), the disk diffusion method (2 of 5), or the other systems (3 of 3). Of 19 MicroScan system users, 18 used the conventional MicroScan Positive Breakpoint Combo Type 6 panel, while 1 used the Type 8 panel. All Vitek users used the Gram-Positive Susceptibility card. Overall, the accuracies of the participating laboratories varied from 50 to 100% for vancomycin, 42 to 100% for penicillin, and 44 to 100% for ampicillin (Table 3). The accuracies for vancomycin were related to the level of resistance: 100% for high-level resistance (VanA;, 512 g/ml), 91% (strain 2) and 97% (strain 3) for moderate resistance (VanB-like;, 32 to 64 g/ml), 84% for low-level resistance (VanB;, 16 to 32 g/ml), 50% for the intermediate E. gallinarum strain (VanC;, 8 g/ml), and 100% for vancomycin susceptibility (, 2 g/ml). Users of all test systems reported vancomycin s that were in agreement with the reference s for strains 1 and 6. All MicroScan Touchscan (AutoSCAN) users additionally reported s in agreement with reference s for strains 3, 4, and 5, while all WalkAway users reported s in agreement with reference s for strains 2, 3, and 5. Test s differed from reference s for MicroScan users for strain 2 (reference, 64 g/ml), which two AutoSCAN users classified as intermediate (, 16 g/ml), and strain 4 (reference s, 16 to 32 g/ml), which two MicroScan WalkAway users classified as intermediate (, 8 g/ml) and one WalkAway user classified as susceptible (, 4 g/ml). For strain 5 (E. gallinarum;, 8 g/ml), all MicroScan users reported s of vancomycin within a single dilution of the reference value. All five AutoSCAN users, five of eight Touchscan users, and three of six WalkAway users classified it as intermediate (s, 8 g/ml). Three Touchscan users reported s of 4 g/ml, but one classified the strain as resistant on the basis of screen plate growth. Two WalkAway users classified it as susceptible (, 4 g/ml), while another classified it as resistant (, 8 g/ml) on the basis of screen plate growth. The Vitek system was unable to detect vancomycin resistance in strains 2 and 4. Three laboratories using the Vitek TABLE 2. Methods used by study laboratories for susceptibility testing Primary method a No. (%) of laboratories No. of laboratories using supplemental screen plate MicroScan AutoSCAN (Touchscan) 13 (40.6) 2 WalkAway 6 (18.8) 1 Vitek 5 (15.6) 3 Disk diffusion 5 (15.6) 2 Pasco (Difco) 1 (3.1) 1 Sensititre 1 (3.1) 1 Microbroth dilution 1 (3.1) 1 a One laboratory reported two sets of results by two susceptibility testing methods.
3 2528 ROSENBERG ET AL. J. CLIN. ROBIOL. TABLE 3. Results of susceptibility testing by classification % of laboratories reporting the Antibiotic and strain no. following classification a : S I R Vancomycin (n 32) Penicillin b (n 19) Ampicillin b (n 30) a S, susceptible; I, intermediate; R, resistant. Boldface type indicates the correct result. b No intermediate category for penicillin and ampicillin is recognized by NC- CLS. system reported vancomycin s of 2 g/ml for strain 2. However, two of these classified it as resistant on the basis of the growth of this strain on screen plates, together with another Vitek user that did not report an. Four of five Vitek users reported s of 2 g/ml for strain 4, although three classified this organism as vancomycin resistant on the basis of growth on the screen plate. All four Vitek users classified strain 5 (E. gallinarum) as resistant to vancomycin (s, 32 g/ml). All disk diffusion users classified strains 1 and 2 (reference zone size, 6 mm for each strain) as resistant to vancomycin; all reported a zone size of 6 mm for strain 1, while for strain 2, zone sizes ranged from 6 to 14 mm. Disk diffusion users reported a range of zone sizes and/or classification errors for vancomycin susceptibility for the remainder of the vancomycin-resistant strains. Strain 3 (reference zone size, 11 mm) was misclassified as susceptible by one participant using disk diffusion, in spite of a zone size of 12 mm. Two disk diffusion users classified strain 4 (reference zone size, 15 mm) as resistant (zone sizes, 12 and 13 mm). One participant reported a zone size of 15 mm but classified the strain as susceptible instead of intermediate. One laboratory classified it as susceptible (zone size, 18 mm). One laboratory classified the strain as intermediate, on the basis of a zone size of 20 mm and screen plate growth. The same laboratory classified strain 6 as susceptible, with a zone size of 19 mm and no growth on the screen plate. Two of six disk diffusion users classified strain 5 (E. gallinarum; reference zone size, 17 mm) as susceptible (zone size, 17 mm); an additional laboratory classified it as susceptible (zone size, 19 mm). Two laboratories classified the isolate as intermediate, one with a zone size of 16 mm and the other with a zone size of 18 mm and growth on the screen plate. One laboratory classified the organism as resistant (zone size, 18 mm) on the basis of screen plate growth. Strain 6 (reference zone size, 18 mm) was correctly classified by all disk diffusion users as susceptible to vancomycin (zone sizes, 17 to 21 mm). BHI screen plate results were provided for each strain by 11 laboratories. Strains 1 through 5 were all reported as showing growth on the screen plate, while strain 6 was reported as showing no growth on the screen plate. Of the 77 sets of strains for which results were reported, 65 (84%) were correctly classified as resistant or susceptible to vancomycin on the basis of s or zone sizes, and the results were corroborated by growth or no growth on the screen plate, including 11 of 11 sets for strains 1, 3, and 6. Eight laboratories modified vancomycin susceptibility classifications for 12 sets of strains on the basis of growth on screen plates. Three Vitek users classified strains 2 and 4 (s, 2 g/ml) as resistant. One disk diffusion user classified strain 4 (zone size, 20 mm) and strain 5 (zone size, 18 mm) as intermediate. Strain 5 was classified as resistant by one MicroScan WalkAway and one broth microdilution user (s, 4 g/ml) and one disk diffusion user (zone size, 18 mm). One MicroScan Touchscan user misclassified strain 5 as resistant (, 8 g/ml). Of the study participants, 8 of 18 (42%) correctly classified strain 1 as resistant to penicillin and 28 of 30 (93%) reported that this strain was susceptible to ampicillin. Of the MicroScan system users, three of eight Touchscan (AutoSCAN) users and one of four WalkAway users classified the strain as resistant to penicillin (s, 8 g/ml). Most of the penicillin or ampicillin susceptibility results for strains 2, 3, 4, and 5 were correct. One disk diffusion user classified strains 3, 4, and 5 as intermediate to penicillin (zone sizes, 16 to 18 mm). All 23 laboratories that routinely tested enterococci for lactamase production (by the nitrocefin disk method) reported that strain 6 was a -lactamase producer; of these, 2 failed to classify the organism as resistant to either -lactam antibiotic. Three disk diffusion users classified the organism as susceptible to ampicillin (zone sizes, 18, 21, and 22 mm, respectively). One laboratory classified the organism as resistant to ampicillin (zone size, 16 mm), while another laboratory classified it as resistant on the basis of -lactamase production and a zone size of 22 mm. Two disk diffusion users classified the organism as resistant to penicillin (zone sizes, 13 and 14 mm, respectively). DISCUSSION Accurate and reproducible results are critical to the success of any laboratory-based study or surveillance system (6). While all the laboratories in our surveillance system were capable of detecting high-level vancomycin resistance mediated by vana, problems in the detection of lesser degrees of vancomycin resistance were identified, providing an opportunity for the correction of these problems. Previous studies have reported greater degrees of difficulty in detecting low-level vancomycin resistance for both automated and nonautomated commercially available systems (28, 30, 31, 35, 37, 39). For example, strain 2 was correctly identified as resistant by 91% of laboratories in the current study, whereas 22 of 76 (29%) clinical laboratories in New Jersey in 1993 identified the organism as resistant (30). This improved performance is partially accounted for by the high proportion of laboratories that use the MicroScan test systems, which were better able to detect resistance in strains 2 and 3 (VanB-like and VanB phenotypes, respectively) than the Vitek system, and to the use of the BHI agar screen. These results are consistent with those of a recent study confirming the ability of the conventional MicroScan panels, which were used exclusively by laboratories in our
4 VOL. 35, 1997 REPORTING OF VANCOMYCIN-RESISTANT ENTEROCOCCI 2529 study, to detect vancomycin and ampicillin resistance in enterococci (12). With the possible exception of the 13 Touchscan (AutoSCAN) users, the small number of users of any one system in the study suggests that caution must be used when interpreting our data. One-third of laboratories participating in the study routinely used BHI agar containing vancomycin as a supplemental screen for vancomycin resistance. For 85% of the tests in which this was done, the screen plate results provided corroboration of the results obtained by the primary method of testing. For 11 of 12 strains with discrepant results, laboratories used growth on screen plates to change the classification from susceptible to resistant (n 8, including 7 resistant strains) or intermediate (n 3, including 1 intermediate strain), thus preventing inaccurate reporting of resistant or intermediate strains as susceptible. Since the study was conducted, a number of additional laboratories have begun using the screen plate as a supplemental test and, in a few instances, as the initial test for vancomycin resistance. In one instance, a Vitek user experienced an outbreak of vancomycin-resistant enterococci in which the epidemic strain manifested the vanb phenotype; the addition of a supplemental screen plate indicated that 67% of the resistant isolates had not been detected by the Vitek system (unpublished data). The results of our study support the use of a screening process such as one with BHI-vancomycin agar, which has a sensitivity and a specificity of 100 and 96 to 99%, respectively (29), as a cost-effective supplement to susceptibility testing for vancomycin (31, 35), as currently recommended by NCCLS (23, 24). Compliance by laboratories with NCCLS guidelines was incomplete with regard to testing of enterococci for -lactamase production (22), because only 74% of laboratories recognized the -lactamase-producing isolate. A number of laboratories misclassified isolates as intermediate to -lactam antibiotics, a category not included in NCCLS guidelines for test systems that use s. Additionally, some laboratories reported test or zone results in agreement with reference values but failed to use NCCLS-recommended breakpoints and therefore reported incorrect interpretations. Compliance with NCCLS guidelines would have eliminated a large proportion of the reporting problems in this study. This survey provides further evidence of the critical role of the susceptibility testing method in the accuracy of reporting of antimicrobial resistance. There is likely to be geographic and temporal variability in the testing methods used by clinical laboratories. Because of cost and volume considerations, standardization of antimicrobial susceptibility testing, as recommended by the American Society for Microbiology (1), may be difficult to achieve for clinical microbiology laboratories on a regional basis. Nevertheless, in multicenter studies or state- or region-based reporting systems, for laboratory-based surveillance for antimicrobial resistance to be effective, studies should be conducted to validate proficiency and the results should be used to ensure adequate testing performance levels. Caution is advised in interpreting multicenter antimicrobial susceptibility test data when, as is often the case, such studies have not preceded data collection. ACKNOWLEDGMENTS We acknowledge the microbiology laboratory supervisors and technicians at each of the participating laboratories, without whom this study could not have been accomplished. REFERENCES 1. ASM Task Force on Antibiotic Resistance Report of the ASM Task Force on Antibiotic Resistance. American Society for Microbiology, Washington, D.C. 2. Boyce, J. M., S. M. Opal, J. W. Chow, M. J. Zervos, G. Potter-Byone, C. B. Sherman, R. L. C. Romulo, S. Fortna, and A. A. Medeiros Outbreak of multidrug-resistant Enterococcus faecium with transferable vanb class vancomycin resistance. J. Clin. Microbiol. 32: Boyle, J. F., S. A. Soumakis, A. Rendo, J. A. Herrington, D. G. Gianarkis, B. E. Thurberg, and B. G. Painter Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J. Clin. Microbiol. 31: Centers for Disease Control and Prevention Addressing emerging infectious disease threats. A prevention strategy for the United States. Centers for Disease Control and Prevention, Atlanta, Ga. 5. Centers for Disease Control and Prevention Statewide surveillance for antibiotic-resistant bacteria New Jersey, Morbid. Mortal. Weekly Rep. 44: Centers for Disease Control and Prevention Assessment of testing for and completeness of reporting of vancomycin-resistant enterococci Morbid. Mortal. Weekly Rep. 45: Frieden, T. R., S. S. Munsiff, D. E. Low, B. M. Wiley, G. Williams, Y. Faur, W. Eisner, S. Warren, and B. Kreisworth Emergence of vancomycinresistant enterococci in New York City. Lancet 342: Gaynes, R Surveillance of antibiotic resistance: learning to live with bias. Infect. Control Hosp. Epidemiol. 16: Handwerger, S., B. Raucher, D. Altarac, J. Monka, S. Marchione, K. V. Singh, B. E. Murray, J. Wolff, and B. Walters Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin. Infect. Dis. 16: Hospital Infection Control Practices Advisory Committee Recommendations for preventing the spread of vancomycin-resistant enterococci. Infect. Control Hosp. Epidemiol. 16: Institute of Medicine Emerging infections: microbial threats to health in the United States. National Academy Press, Washington, D.C. 12. Iwen, P. C., D. M. Kelly, J. Lindner, and S. H. Hinrichs Revised approach for identification and detection of ampicillin and vancomycin resistance in Enterococcus species by using MicroScan panels. J. Clin. Microbiol. 34: Kaplan, A. H., P. H. Gilligan, and R. R. Facklam Recovery of resistant enterococci during vancomycin prophylaxis. J. Clin. Microbiol. 26: Karanfil, L. V., M. Murphy, A. Josephson, R. Gaynes, L. Mandel, B. C. Hill, and J. M. Swenson A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit. Infect. Control Hosp. Epidemiol. 13: Krogstad, D. J., T. R. Korfhagen, R. C. Moellering, Jr., C. Wennersten, and M. N. Swartz Aminoglycoside-inactivating enzymes in clinical isolates of Streptococcus faecalis: an explanation for antibiotic synergism. J. Clin. Invest. 62: Leclerq, R., E. Derlot, J. Duval, and P. Courvalin Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N. Engl. J. Med. 319: Lorian, V The need for surveillance for antimicrobial resistance. Infect. Control Hosp. Epidemiol. 16: Morris, J. G., Jr., D. K. Shay, J. N. Hebden, R. J. McCarter, B. E. Perdue, W. Jarvis, J. A. Johnson, T. C. Dowling, L. B. Polish, and R. S. Schwalbe Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center. Ann. Intern. Med. 123: Murray, B. E The life and times of the enterococcus. Clin. Microbiol. Rev. 3: Murray, B. E Can antibiotic resistance be controlled? N. Engl. J. Med. 330: Murray, B. E., and B. Mederski-Samoraj Transferable -lactamase: a new mechanism for in vitro penicillin resistance in Streptococcus faecalis. J. Clin. Invest. 72: National Committee for Clinical Laboratory Standards Third information supplement M100-S3. Performance standards for antimicrobial susceptibility testing. National Committee for Clinical Laboratory Standards, Villanova, Pa. 23. National Committee for Clinical Laboratory Standards Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa. 24. National Committee for Clinical Laboratory Standards Performance standards for antimicrobial disk susceptibility tests, 5th ed. Approved standard M2-A5. National Committee for Clinical Laboratory Standards, Villanova, Pa. 25. Osterholm, M. T., and K. L. MacDonald Antibiotic-resistant bugs: when, where, and why? Infect. Control Hosp. Epidemiol. 16: Paul, S. M., L. Finelli, G. L. Crane, and K. C. Spitalny A statewide surveillance system for antimicrobial-resistant bacteria: New Jersey. Infect. Control Hosp. Epidemiol. 16: Rubin, L. G., V. Tucci, E. Cercenado, G. Eliopoulos, and H. D. Isenberg Vancomycin-resistant Enterococcus faecium in hospitalized children.
5 2530 ROSENBERG ET AL. J. CLIN. ROBIOL. Infect. Control. Hosp Epidemiol. 13: Sahm, D. F., and L. Olsen In vitro detection of enterococcal vancomycin resistance. Antimicrob. Agents Chemother. 34: Swenson, J. M., N. C. Clark, M. J. Ferraro, D. F. Sahm, G. Doern, M. A. Pfaller, L. B. Reller, M. P. Weinstein, R. J. Zabransky, G. L. Woods, and F. C. Tenover Development of a standardized screening method for detection of vancomycin-resistant enterococci. J. Clin. Microbiol. 32: Tenover, F. C., J. Tokars, J. Swenson, S. Paul, K. Spitalny, and W. Jarvis Ability of clinical laboratories to detect antimicrobial agent-resistant enterococci. J. Clin. Microbiol. 31: Tenover, F. C., J. Swenson, C. M. O Hara, and S. A. Stocker Ability of commercial and reference antimicrobial susceptibility testing methods to detect vancomycin resistance in enterococci. J. Clin. Microbiol. 33: Tomasz, A Multiple-antibiotic resistant pathogenic bacteria. A report on the Rockefeller University Workshop. N. Engl. J. Med. 330: Walsh, C. T Vancomycin resistance: decoding the molecular logic. Science 261: Wells, C. L., B. A. Juni, S. B. Cameron, K. R. Mason, D. L. Dunn, P. Ferrieri, and F. S. Rhame Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients. Clin. Infect. Dis. 21: Wiley, B. M., B. N. Kreiswirth, A. E. Simor, G. Williams, S. R. Scriver, A. Phillips, and D. E. Low Detection of vancomycin resistance in Enterococcus species. J. Clin. Microbiol. 30: Williamson, R., C. LeBouguenec, L. Gutmann, and T. Horaud One or two low affinity penicillin-binding proteins may be responsible for the range of susceptibility of Enterococcus faecium to benzylpenicillin. J. Gen. Microbiol. 131: Woodford, N., A. P. Johnson, D. Morrison, and D. C. E. Speller Current perspectives on glycopeptide resistance. Clin. Microbiol. Rev. 8: Woods, G. L., and J. A. Washington Antibacterial susceptibility tests: dilution and disk diffusion methods, p In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C. 39. Zabransky, R. J., A. R. DiNuzzo, M. B. Huber, and G. L. Woods Detection of vancomycin resistance in enterococci by the Vitek AMS system. Diagn. Microbiol. Infect. Dis. 20:
Agent-Resistant Enterococci
JOURNAL OF CLINICAL MICROBIOLOGY, July 1993, p. 1695-1699 0095-1137/93/071695-05$02.00/0 Copyright 1993, American Society for Microbiology Vol. 31, No. 7 Ability of Clinical Laboratories To Detect Antimicrobial
More informationSusceptibility Testing of Clinical Isolates of Enterococcus faecium
JOURNAL OF CLINICAL MICROBIOLOGY, Jan. 1992, p. 41-45 0095-1137/92/010041-05$02.00/0 Copyright 1992, American Society for Microbiology Vol. 30, No. 1 Susceptibility Testing of Clinical Isolates of Enterococcus
More informationAbility of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of Project ICARE laboratories
Diagnostic Microbiology and Infectious Disease 38 (2000) 59 67 Surveillance www.elsevier.com/locate/diagmicrobio Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens:
More informationagainst Clinical Isolates of Gram-Positive Bacteria
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 993, p. 366-370 Vol. 37, No. 0066-0/93/00366-05$0.00/0 Copyright 993, American Society for Microbiology In Vitro Activity of CP-99,9, a New Fluoroquinolone,
More informationANTIMICROBIAL SUSCEPTIBILITY VANCOMYCIN RESISTANCE IN AN UNCOMMON ENTEROCOCCAL SPECIES
ENTEROCOCCAL SPECIES Sample ES-02 was a simulated blood culture isolate from a patient with symptoms of sepsis. Participants were asked to identify any potential pathogen and to perform susceptibility
More informationJasmine M. Chaitram, 1,2 * Laura A. Jevitt, 1,2 Sara Lary, 1,2 Fred C. Tenover, 1,2 and The WHO Antimicrobial Resistance Group 3,4
JOURNAL OF CLINICAL MICROBIOLOGY, June 2003, p. 2372 2377 Vol. 41, No. 6 0095-1137/03/$08.00 0 DOI: 10.1128/JCM.41.6.2372 2377.2003 The World Health Organization s External Quality Assurance System Proficiency
More informationEDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update
EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain
More informationBackground and Plan of Analysis
ENTEROCOCCI Background and Plan of Analysis UR-11 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony count, to perform the identification
More informationENTEROCOCCI. April Abbott Deaconess Health System Evansville, IN
ENTEROCOCCI April Abbott Deaconess Health System Evansville, IN OBJECTIVES Discuss basic antimicrobial susceptibility principles and resistance mechanisms for Enterococcus Describe issues surrounding AST
More informationUse of the National Committee for Clinical Laboratory Standards Guidelines for Disk Diffusion Susceptibility Testing in New York State Laboratories
JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 2000, p. 3341 3348 Vol. 38, No. 9 0095-1137/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Use of the National Committee for
More informationEvaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals
J Vet Diagn Invest :164 168 (1998) Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals Susannah K. Hubert, Phouc Dinh Nguyen, Robert D. Walker Abstract.
More informationSUPPLEMENT ARTICLE. Donald E. Low, 1 Nathan Keller, 2 Alfonso Barth, 3 and Ronald N. Jones 4
SUPPLEMENT ARTICLE Clinical Prevalence, Antimicrobial Susceptibility, and Geographic Resistance Patterns of Enterococci: Results from the SENTRY Antimicrobial Surveillance Program, 1997 1999 Donald E.
More informationChristiane Gaudreau* and Huguette Gilbert
Journal of Antimicrobial Chemotherapy (1997) 39, 707 712 JAC Comparison of disc diffusion and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni subsp. jejuni and Campylobacter
More informationESCMID Online Lecture Library. by author
Quality Assurance of antimicrobial susceptibility testing Derek Brown EUCAST Scientific Secretary ESCMID Postgraduate Education Course, Linz, 17 September 2014 Quality Assurance The total process by which
More informationPlease distribute a copy of this information to each provider in your organization.
HEALTH ADVISORY TO: Physicians and other Healthcare Providers Please distribute a copy of this information to each provider in your organization. Questions regarding this information may be directed to
More informationMICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC
MICRONAUT Detection of Resistance Mechanisms Innovation with Integrity BMD MIC Automated and Customized Susceptibility Testing For detection of resistance mechanisms and specific resistances of clinical
More informationTel: Fax:
CONCISE COMMUNICATION Bactericidal activity and synergy studies of BAL,a novel pyrrolidinone--ylidenemethyl cephem,tested against streptococci, enterococci and methicillin-resistant staphylococci L. M.
More informationFecal Emergence of Vancomycin-Resistant Enterococci after Prophylactic Intravenous Vancomycin
ISPUB.COM The Internet Journal of Infectious Diseases Volume 2 Number 2 Fecal Emergence of Vancomycin-Resistant Enterococci after Prophylactic Intravenous Vancomycin E Nahum, Z Samra, J Ben-Ari, O Dagan,
More informationNew Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs
New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs Patrick R. Murray, PhD Senior Director, WW Scientific Affairs 2017 BD. BD, the BD Logo and all other trademarks
More informationESCMID Online Lecture Library. by author
Expert rules in susceptibility testing EUCAST-ESGARS-EPASG Educational Workshop Linz, 16 19 September, 2014 Dr. Rafael Cantón Hospital Universitario Ramón y Cajal SERVICIO DE MICROBIOLOGÍA Y PARASITOLOGÍA
More informationEpidemiologic Analysis and Genotypic Characterization of a Nosocomial Outbreak of Vancomycin-Resistant Enterococci
JOURNAL OF CLINICAL MICROBIOLOGY, May 1993, p. 1280-1285 0095-1137/93/051280-06$02.00/0 Copyright ) 1993, American Society for Microbiology Vol. 31, No. 5 Epidemiologic Analysis and Genotypic Characterization
More informationOutbreak of Vancomycin-, Ampicillin-, and Aminoglycoside- Resistant Enterococcus faecium Bacteremia in an Adult Oncology Unit
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, June 1994, p. 1363-1367 66-484/94/$4.+ Copyright X) 1994, American Society for Microbiology Vol. 38, No. 6 Outbreak of Vancomycin-, Ampicillin-, and Aminoglycoside-
More informationORIGINAL INVESTIGATION
Enterococcus faecium Bacteremia Does Vancomycin Resistance Make a Difference? Valentina Stosor, MD; Lance R. eterson, MD; Michael ostelnick, Rh; Gary A. Noskin, MD ORIGINAL INVESTIGATION Background: Enterococcus
More informationPrevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 4 Number 9 (2015) pp. 952-956 http://www.ijcmas.com Original Research Article Prevalence of Metallo-Beta-Lactamase
More informationDecrease of vancomycin resistance in Enterococcus faecium from bloodstream infections in
AAC Accepted Manuscript Posted Online 30 March 2015 Antimicrob. Agents Chemother. doi:10.1128/aac.00513-15 Copyright 2015, American Society for Microbiology. All Rights Reserved. 1 2 Decrease of vancomycin
More informationEducating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges
Educating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges Janet Hindler, MCLS MT(ASCP) UCLA Medical Center jhindler@ucla.edu also working as a consultant with the Association
More informationNine episodes of CPD-associated peritonitis with vancomycin resistant enterococci
Kidney International, Vol. 50 (1996), pp. 1368 1372 RAPID COMMUNICATION Nine episodes of CPD-associated peritonitis with vancomycin resistant enterococci LAURA TROIDLE, ALAN 5. KLIGER, NANCY GORBAN-BRENNAN,
More informationPerformance Information. Vet use only
Performance Information Vet use only Performance of plates read manually was measured in three sites. Each centre tested Enterobacteriaceae, streptococci, staphylococci and pseudomonas-like organisms.
More informationPrinciples of Antimicrobial Therapy
Principles of Antimicrobial Therapy Doo Ryeon Chung, MD, PhD Professor of Medicine, Division of Infectious Diseases Director, Infection Control Office SUNGKYUNKWAN UNIVERSITY SCHOOL OF MEDICINE CASE 1
More informationTHE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS
THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS Stefanie Desmet University Hospitals Leuven Laboratory medicine microbiology stefanie.desmet@uzleuven.be
More informationQuality assurance of antimicrobial susceptibility testing
Quality assurance of antimicrobial susceptibility testing Derek Brown Routine quality control Repeated testing of controls in parallel with tests to ensure that the test system is performing reproducibly
More informationANTIMICROBIAL SUSCEPTIBILITY CONTEMPORARY SUSCEPTIBILITY TESTS AND TREATMENTS FOR VRE INFECTIONS
TREATMENTS FOR VRE INFECTIONS Sample ES-01 (2015) was a simulated blood culture isolate from a patient with associated clinical symptoms (pure culture). Participants were requested to identify any potential
More informationPILOT STUDY OF THE ANTIMICROBIAL SUSCEPTIBILITY OF SHIGELLA IN NEW ZEALAND IN 1996
PILOT STUDY OF THE ANTIMICROBIAL SUSCEPTIBILITY OF SHIGELLA IN NEW ZEALAND IN 996 November 996 by Maggie Brett Antibiotic Reference Laboratory ESR Communicable Disease Centre Porirua CONTENTS Page SUMMARY
More informationAPPENDIX III - DOUBLE DISK TEST FOR ESBL
Policy # MI\ANTI\04\03\v03 Page 1 of 5 Section: Antimicrobial Susceptibility Testing Manual Subject Title: Appendix III - Double Disk Test for ESBL Issued by: LABORATORY MANAGER Original Date: January
More informationConsequences of Antimicrobial Resistant Bacteria. Antimicrobial Resistance. Molecular Genetics of Antimicrobial Resistance. Topics to be Covered
Antimicrobial Resistance Consequences of Antimicrobial Resistant Bacteria Change in the approach to the administration of empiric antimicrobial therapy Increased number of hospitalizations Increased length
More informationESBL Producers An Increasing Problem: An Overview Of An Underrated Threat
ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat Hicham Ezzat Professor of Microbiology and Immunology Cairo University Introduction 1 Since the 1980s there have been dramatic
More informationMID 23. Antimicrobial Resistance. Consequences of Antimicrobial Resistant Bacteria. Molecular Genetics of Antimicrobial Resistance
Antimicrobial Resistance Molecular Genetics of Antimicrobial Resistance Micro evolutionary change - point mutations Beta-lactamase mutation extends spectrum of the enzyme rpob gene (RNA polymerase) mutation
More informationAntimicrobial Resistance
Antimicrobial Resistance Consequences of Antimicrobial Resistant Bacteria Change in the approach to the administration of empiric antimicrobial therapy Increased number of hospitalizations Increased length
More informationAntimicrobial Resistance Acquisition of Foreign DNA
Antimicrobial Resistance Acquisition of Foreign DNA Levy, Scientific American Horizontal gene transfer is common, even between Gram positive and negative bacteria Plasmid - transfer of single or multiple
More informationShort Report. R Boot. Keywords: Bacteria, antimicrobial susceptibility testing, quality, diagnostic laboratories, proficiency testing
Short Report Frequent major errors in antimicrobial susceptibility testing of bacterial strains distributed under the Deutsches Krebsforschungszentrum Quality Assurance Program R Boot Former Section of
More informationEvaluation of MicroScan MIC Panels for Detection of
JOURNAL OF CLINICAL MICROBIOLOGY, May 1988, p. 816-820 Vol. 26, No. 5 0095-1137/88/050816-05$02.00/0 Copyright 1988, American Society for Microbiology Evaluation of MicroScan MIC Panels for Detection of
More informationUnderstanding the Hospital Antibiogram
Understanding the Hospital Antibiogram Sharon Erdman, PharmD Clinical Professor Purdue University College of Pharmacy Infectious Diseases Clinical Pharmacist Eskenazi Health 5 Understanding the Hospital
More informationRESEARCH NOTE THE EVALUATION OF ANTIMICROBIAL SUSCEPTIBILITY OF URINE ENTEROCOCCI WITH THE VITEK 2 AUTOMATED SYSTEM IN EASTERN TURKEY
Southeast Asian J Trop Med Public Health RESEARCH NOTE THE EVALUATION OF ANTIMICROBIAL SUSCEPTIBILITY OF URINE ENTEROCOCCI WITH THE VITEK 2 AUTOMATED SYSTEM IN EASTERN TURKEY Sibel AK 1, Köroglu Mehmet
More informationAntimicrobial Susceptibility of Vancomycin-Resistant Leuconostoc, Pediococcus, and Lactobacillus Species
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 99, p. 53-59 Vol. 3, No. 66-/9/53-7$./ Copyright C 99, American Society for Microbiology Antimicrobial Susceptibility of Vancomycin-Resistant,, and Species J.
More informationEDUCATIONAL COMMENTARY CURRENT METHODS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING
Commentary provided by: Linsey Donner, MPH, CPH, MLS (ASCP) CM Assistant Professor, Microbiology and Serology College of Allied Health Professions, Division of Medical Laboratory Science University of
More informationAntimicrobial Resistance Strains
Antimicrobial Resistance Strains Microbiologics offers a wide range of strains with characterized antimicrobial resistance mechanisms including: Extended-Spectrum β-lactamases (ESBLs) Carbapenamases Vancomycin-Resistant
More informationInt.J.Curr.Microbiol.App.Sci (2018) 7(8):
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 08 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.708.378
More informationDetection of inducible clindamycin resistance among clinical isolates of Staphylococcus aureus in a tertiary care hospital
ISSN: 2319-7706 Volume 3 Number 9 (2014) pp. 689-694 http://www.ijcmas.com Original Research Article Detection of inducible clindamycin resistance among clinical isolates of Staphylococcus aureus in a
More informationChemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance
Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance evolution of antimicrobial resistance Mechanism of bacterial genetic variability Point mutations may occur in a nucleotide base pair,
More informationSynergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci
Journal of Antimicrobial Chemotherapy (78) 4, 53-543 Synergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci Chatrchal Watanakunakoni and Cheryl Glotzbecker Infectious
More informationKey words: Campylobacter, diarrhea, MIC, drug resistance, erythromycin
Key words: Campylobacter, diarrhea, MIC, drug resistance, erythromycin Table 1 Detection rate of Campylobacter from stool samples taken from sporadic diarrheic patients Table 2 Detection rates of Campylobacter
More informationDefining Extended Spectrum b-lactamases: Implications of Minimum Inhibitory Concentration- Based Screening Versus Clavulanate Confirmation Testing
Infect Dis Ther (2015) 4:513 518 DOI 10.1007/s40121-015-0094-6 BRIEF REPORT Defining Extended Spectrum b-lactamases: Implications of Minimum Inhibitory Concentration- Based Screening Versus Clavulanate
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXIII NUMBER 1 July 2008 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell, SM (ASCP), Marti Roe SM (ASCP), Ann-Christine Nyquist MD, MSPH Are the bugs winning? The 2007
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The
More informationIs There a Relationship Between Vancomycin-Resistant Enterococcal Infection and Clostridium difficile Infection?
S206 Is There a Relationship Between Vancomycin-Resistant Enterococcal Infection and Clostridium difficile Infection? Dale N. Gerding From the Medical Service, Chicago Veterans Affairs Healthcare System
More informationBBL CHROMagar MRSA Rev. 05 October 2008
I II III IV V VI VII BBL CHROMagar MRSA 8012632 Rev. 05 October 2008 QUALITY CONTROL PROCEDURES INTRODUCTION BBL CHROMagar MRSA, supplemented with chromogens and inhibitory agents, is used for the qualitative
More informationSusceptibility Testing and Resistance Phenotypes Detection in Bacterial Pathogens Using the VITEK 2 System
Polish Journal of Microbiology 2005, Vol. 54, No 4, 311 316 Susceptibility Testing and Resistance Phenotypes Detection in Bacterial Pathogens Using the VITEK 2 System EL BIETA STEFANIUK*, AGNIESZKA MRÓWKA
More informationa. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.
AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony
More informationFlorida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC
Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC 11/20/2014 1 To describe carbapenem-resistant Enterobacteriaceae. To identify laboratory detection standards for carbapenem-resistant
More informationAntimicrobial Resistance Surveillance from sentinel public hospitals, South Africa, 2013
Antimicrobial Resistance Surveillance from sentinel public s, South Africa, 213 Authors: Olga Perovic 1,2, Melony Fortuin-de Smidt 1, and Verushka Chetty 1 1 National Institute for Communicable Diseases
More informationSummary of the latest data on antibiotic resistance in the European Union
Summary of the latest data on antibiotic resistance in the European Union EARS-Net surveillance data November 2017 For most bacteria reported to the European Antimicrobial Resistance Surveillance Network
More informationPrinciples and Practice of Antimicrobial Susceptibility Testing. Microbiology Technical Workshop 25 th September 2013
Principles and Practice of Antimicrobial Susceptibility Testing Microbiology Technical Workshop 25 th September 2013 Scope History Why Perform Antimicrobial Susceptibility Testing? How to Perform an Antimicrobial
More information2 0 hr. 2 hr. 4 hr. 8 hr. 10 hr. 12 hr.14 hr. 16 hr. 18 hr. 20 hr. 22 hr. 24 hr. (time)
Key words I μ μ μ μ μ μ μ μ μ μ μ μ μ μ II Fig. 1. Microdilution plate. The dilution step of the antimicrobial agent is prepared in the -well microplate. Serial twofold dilution were prepared according
More informationORIGINAL ARTICLE. influenzae and Moraxella catarrhalis to antimicrobial agents used to treat respiratory tract infections.
ORIGINAL ARTICLE Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997 98 I. A. Critchley 1, C. Thornsberry
More informationDetection of Methicillin Resistant Strains of Staphylococcus aureus Using Phenotypic and Genotypic Methods in a Tertiary Care Hospital
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 7 (2017) pp. 4008-4014 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.607.415
More informationMultiple drug resistance pattern in Urinary Tract Infection patients in Aligarh
Multiple drug resistance pattern in Urinary Tract Infection patients in Aligarh Author(s): Asad U Khan and Mohd S Zaman Vol. 17, No. 3 (2006-09 - 2006-12) Biomedical Research 2006; 17 (3): 179-181 Asad
More informationActivity of Linezolid Tested Against Uncommonly Isolated Gram-positive ACCEPTED
AAC Accepts, published online ahead of print on 8 January 2007 Antimicrob. Agents Chemother. doi:10.1128/aac.01496-06 Copyright 2007, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationReceived 15 October 2006/Returned for modification 20 December 2006/Accepted 15 February 2007
JOURNAL OF CLINICAL MICROBIOLOGY, May 2007, p. 1556 1560 Vol. 45, No. 5 0095-1137/07/$08.00 0 doi:10.1128/jcm.02116-06 Copyright 2007, American Society for Microbiology. All Rights Reserved. Evaluation
More informationOriginal Article. Hossein Khalili a*, Rasool Soltani b, Sorrosh Negahban c, Alireza Abdollahi d and Keirollah Gholami e.
Iranian Journal of Pharmaceutical Research (22), (2): 559-563 Received: January 2 Accepted: June 2 Copyright 22 by School of Pharmacy Shaheed Beheshti University of Medical Sciences and Health Services
More informationIntrinsic, implied and default resistance
Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been
More informationIn Vitro Antimicrobial Activity of CP-99,219, a Novel Azabicyclo-Naphthyridone
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 993, p. 39-353 0066-0/93/0039-05$0.00/0 Copyright 993, American Society for Microbiology Vol. 37, No. In Vitro Antimicrobial Activity of, a Novel Azabicyclo-Naphthyridone
More informationORIGINAL INVESTIGATION. The Role of Colonization Pressure in the Spread of Vancomycin-Resistant Enterococci
The Role of Colonization Pressure in the Spread of Vancomycin-Resistant Enterococci An Important Infection Control Variable ORIGINAL INVESTIGATION Marc J. M. Bonten, MD; Sarah Slaughter, MD; Anton W. Ambergen;
More informationPractical approach to Antimicrobial susceptibility testing (AST) and quality control
Practical approach to Antimicrobial susceptibility testing (AST) and quality control A/Professor John Ferguson, Microbiologist & Infectious Diseases Physician, Pathology North, University of Newcastle,
More informationMolecular and clinical epidemiology of vancomycin-resistant Enterococcus faecalis
Journal of Antimicrobial Chemotherapy (2004) 53, 626 630 DOI: 10.1093/jac/dkh138 Advance Access publication 18 February 2004 Molecular and clinical epidemiology of vancomycin-resistant Enterococcus faecalis
More informationBrief reports. Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae
Journal of Antimicrobial Chemotherapy (1997) 40, 105 108 Brief reports JAC Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae Andreas Pikis a *, Jacob A. Donkersloot
More informationEvaluation of the AutoMicrobic System for Susceptibility Testing of Aminoglycosides and Gram-Negative Bacilli
JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 1987, p. 546-550 0095-1137/87/030546-05$02.00/0 Copyright C 1987, American Society for Microbiology Vol. 25, No. 3 Evaluation of the AutoMicrobic System for Susceptibility
More informationORIGINAL ARTICLE. Focus Technologies, Inc., 1 Hilversum, The Netherlands, 2 Herndon, Virginia and 3 Franklin, Tennessee, USA
ORIGINAL ARTICLE In vitro susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a European multicenter study during 2000 2001 M. E. Jones 1, R. S. Blosser-Middleton
More informationORIGINAL ARTICLE /j x. and 2 Department of Infectious Diseases, Westmead Hospital, Westmead, New South Wales, Australia
ORIGINAL ARTICLE 10.1111/j.1469-0691.2008.02052.x Difficulties in detection and identification of Enterococcus faecium with low-level inducible resistance to vancomycin, during a hospital outbreak S. Pendle
More informationSafe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times
Safe Patient Care Keeping our Residents Safe 2016 Use Standard Precautions for ALL Residents at ALL times #safepatientcare Do bugs need drugs? Dr Deirdre O Brien Consultant Microbiologist Mercy University
More informationBrief Report THE DEVELOPMENT OF VANCOMYCIN RESISTANCE IN A PATIENT WITH METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTION
Brief Report THE DEVELOPMENT OF VANCOMYCIN RESISTANCE IN A PATIENT WITH METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTION KRZYSZTOF SIERADZKI, PH.D., RICHARD B. ROBERTS, M.D., STUART W. HABER, M.D.,
More informationOriginal Article. Ratri Hortiwakul, M.Sc.*, Pantip Chayakul, M.D.*, Natnicha Ingviya, B.Sc.**
Original Article In Vitro Activity of Cefminox and Other β-lactam Antibiotics Against Clinical Isolates of Extended- Spectrum-β-lactamase-Producing Klebsiella pneumoniae and Escherichia coli Ratri Hortiwakul,
More informationQuality Control Testing with the Disk Antibiotic Susceptibility Test of Bauer-Kirby-Sherris-Turck
Quality Control Testing with the Disk Antibiotic Susceptibility Test of Bauer-Kirby-Sherris-Turck DONNA J. BLAZEVIC, M.P.H., MARILYN H. KOEPCKE, B.S., A JOHN M. MATSEN, M.D. Departments of Laboratory Medicine
More informationGlycopeptide Resistant Enterococci (GRE) Policy IC/292/10
BASINGSTOKE AND NORTH HAMPSHIRE NHS FOUNDATION TRUST Glycopeptide Resistant Enterococci (GRE) Policy IC/292/10 Supersedes: IC/292/07 Owner Name Dr Nicki Hutchinson Job Title Consultant Microbiologist,
More informationEvaluation of the BIOGRAM Antimicrobial Susceptibility Test System
JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 1985, p. 793-798 0095-1137/85/110793-06$02.00/0 Copyright 1985, American Society for Microbiology Vol. 22, No. 5 Evaluation of the BIOGRAM Antimicrobial Susceptibility
More informationGUIDE TO INFECTION CONTROL IN THE HOSPITAL. Antibiotic Resistance
GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 4: Antibiotic Resistance Author M.P. Stevens, MD, MPH S. Mehtar, MD R.P. Wenzel, MD, MSc Chapter Editor Michelle Doll, MD, MPH Topic Outline Key Issues
More informationUnusual Increase of Vancomycin-resistant Enterococcus faecium but not Enterococcus faecalis at a University Hospital in Taiwan
Original Article 493 Unusual Increase of Vancomycin-resistant Enterococcus faecium but not Enterococcus faecalis at a University Hospital in Taiwan Ping-Cherng Chiang 1,3, MD; Tsu-Lan Wu 2, MS; Jiunn-Yih
More informationMICHAEL J. RYBAK,* ELLIE HERSHBERGER, TABITHA MOLDOVAN, AND RICHARD G. GRUCZ
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 2000, p. 1062 1066 Vol. 44, No. 4 0066-4804/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. In Vitro Activities of Daptomycin,
More informationKJLM. Evaluation of the MicroScan MICroSTREP Plus Antimicrobial Panel for Testing ß-Hemolytic Streptococci and Viridans Group Streptococci
Korean J Lab Med 2011;31:185-190 Original Article Clinical Microbiology KJLM Evaluation of the MicroScan MICroSTREP Plus Antimicrobial Panel for Testing ß-Hemolytic Streptococci and Viridans Group Streptococci
More informationOpen Access. The Open Microbiology Journal, 2008, 2,
The Open Microbiology Journal, 2008, 2, 79-84 79 Open Access In vitro Antimicrobial Activity of Ampicillin-Ceftriaxone and Ampicillin- Ertapenem Combinations Against Clinical Isolates of Enterococcus faecalis
More informationAntimicrobial Resistance
Antimicrobial Resistance Consequences of Antimicrobial Resistant Bacteria Change in the approach to the administration of Change in the approach to the administration of empiric antimicrobial therapy Increased
More informationEmergence of Vancomycin-Resistant Enterococci
Emergence of Vancomycin-Resistant Enterococci Louis B. Rice VA Medical Center and Case Western Reserve University School of Medicine, Cleveland, Ohio, USA Vancomycin and ampicillin resistance in clinical
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST Version 8.0, valid from 018-01-01
More informationWHY IS THIS IMPORTANT?
CHAPTER 20 ANTIBIOTIC RESISTANCE WHY IS THIS IMPORTANT? The most important problem associated with infectious disease today is the rapid development of resistance to antibiotics It will force us to change
More informationAntibiotic Susceptibility Pattern of Vibrio cholerae Causing Diarrohea Outbreaks in Bidar, North Karnataka, India
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 4 Number 9 (2015) pp. 957-961 http://www.ijcmas.com Original Research Article Antibiotic Susceptibility Pattern
More informationEpidemiology and Microbiology of Surgical Wound Infections
JOURNAL OF CLINICAL MICROBIOLOGY, Feb. 2000, p. 918 922 Vol. 38, No. 2 0095-1137/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Epidemiology and Microbiology of Surgical
More informationAntimicrobial Cycling. Donald E Low University of Toronto
Antimicrobial Cycling Donald E Low University of Toronto Bad Bugs, No Drugs 1 The Antimicrobial Availability Task Force of the IDSA 1 identified as particularly problematic pathogens A. baumannii and
More informationStreptococcus pneumoniae. Oxacillin 1 µg as screen for beta-lactam resistance
Streptococcus pneumoniae Oxacillin µg as screen for beta-lactam resistance Version 6. June Streptococcus pneumoniae and zone diameter correlates The following histograms present inhibition zone diameter
More informationAntimicrobial Resistance and Molecular Epidemiology of Staphylococcus aureus in Ghana
Antimicrobial Resistance and Molecular Epidemiology of Staphylococcus aureus in Ghana Beverly Egyir, PhD Noguchi Memorial Institute for Medical Research Bacteriology Department, University of Ghana Background
More informationClinical Usefulness of Multi-facility Microbiology Laboratory Database Analysis by WHONET
Special Articles Journal of General and Family Medicine 2015, vol. 16, no. 3, p. 138 142. Clinical Usefulness of Multi-facility Microbiology Laboratory Database Analysis by WHONET Sachiko Satake, PhD,
More informationAntibiogram Study of Clinical Isolates of Enterococcus in a Tertiary Care Teaching Hospital
DOI: 10.7860/NJLM/2018/36174:2306 Microbiology Section Original Article Antibiogram Study of Clinical Isolates of Enterococcus in a Tertiary Care Teaching Hospital Riddhi Hathiwala, Archana Bhimrao Wankhade,
More information